Regulatory tracker: Dupixent scores FDA approval to treat bullous pemphigoid

In this tracker, Fierce Pharma is recording the regulatory progress of in-market products, including expansions into key geographies and new indications. Some of these updates may not meet the bar for standalone stories, but we think they are still worth mentioning.

Jun 20, 2025 - 13:40
 0
Regulatory tracker: Dupixent scores FDA approval to treat bullous pemphigoid
In this tracker, Fierce Pharma is recording the regulatory progress of in-market products, including expansions into key geographies and new indications. Some of these updates may not meet the bar for standalone stories, but we think they are still worth mentioning.